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Abstract
Background: Numerous studies have reported that spending time in nature is associated with the improvement of
various health outcomes and well-being. This review evaluated the physical and psychological benefits of a specific
type of exposure to nature, forest therapy.
Method: A literature search was carried out using MEDLINE, PubMed, ScienceDirect, EMBASE, and ProQuest databases
and manual searches from inception up to December 2016. Key words: “Forest” or “Shinrin -Yoku” or “Forest bath” AND
“Health” or “Wellbeing”. The methodological quality of each randomized controlled trials (RCTs) was assessed according
to the Cochrane risk of bias (ROB) tool.
Results: Six RCTs met the inclusion criteria. Participants’ ages ranged from 20 to 79 years. Sample size ranged from 18
to 99. Populations studied varied from young healthy university students to elderly people with chronic disease. Studies
reported the positive impact of forest therapy on hypertension (n= 2), cardiac and pulmonary function (n = 1), immune
function (n = 2), inflammation (n= 3), oxidative stress (n = 1), stress (n = 1), stress hormone (n= 1), anxiety (n= 1),
depression (n = 2), and emotional response (n = 3). The quality of all studies included in this review had a high ROB.
Conclusion: Forest therapy may play an important role in health promotion and disease prevention. However, the lack of
high-quality studies limits the strength of results, rendering the evidence insufficient to establish clinical practice
guidelines for its use. More robust RCTs are warranted.
Keywords: Nature, Forest, Health, Wellbeing, Green environment
Background
There is a growing interest in the health benefits associ-
ated with individuals undertaking outdoor activities in a
natural environment [1, 2]. Forests and other natural
environments are recognized as fundamental health
resources and may play a role in disease prevention [3],
with one population survey reporting that the average
person spends almost 90% of their life indoors [4].
Since the development of the concept of nature as a
therapy in the 1990s [5, 6], a number of studies using a
variety of methodologies, have been conducted to exam-
ine the effect of forest environments on health promo-
tion and well-being. Several recent environmental
studies have claimed that a number of medical symp-
toms related to lifestyle stress can be treated by encour-
aging individuals to interact with nature [7].
Furthermore, one study revealed an association between
positive health outcomes and the amount of exposure an
individual has to a green environment [8].
Moreover, research conducted in a very specific
natural context, exposure to “forests”, or “forest ther-
apy”, have reported potential benefits in the manage-
ment of psychological symptoms including anxiety [9],
depression [9], mood disorder [10], burnout syndrome
[11], lifestyle-related stress [12], and overall quality of
life [13]. Studies investigating the effect of forest therapy
on physiological well-being have also demonstrated a
positive impact on cognitive function [14], immune
function [15, 16], blood glucose levels in diabetic
patients [17], hypertension [18], cardiovascular disease
[19], cancer [20], and pain [21]. Earlier studies
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conducted with surgical patients suggest that exposure
to a green environment is associated with the recovery
of illness and even decreased mortality [22–24].
Despite a number of studies providing preliminary
evidence linking exposure to a natural, green forest en-
vironment and positive psychological and physiological
benefits [25–27], most health professionals have failed to
recommend nor integrate such therapy for the manage-
ment or prevention of disease during their medical
consultations [24]. As yet, there are no evidence-based
clinical practice guidelines for the use of such therapy
for healthcare professionals. In previous literature re-
views [1], authors have attempted to draw conclusions
regarding the therapeutic benefits of forest therapy but
doubt remains regarding its efficacy and value [28].
While the theory of forest therapy [5, 6], the belief that
taking time out in nature, specifically a forest area, can
affect human well-being and heath, was first proposed in
Western countries, it was researchers from Japan that
instigated studies to evaluate the therapeutic effect of
spending time in forests on health and well-being. These
Japanese studies influenced further research in Korea,
China, and Europe. It was the Japanese who coined the
term “shinrin-yoku” to depict activities of recreation and
relaxation in a forest. Shinrin-yoku specifically relates to
the activity of forest bathing, staying and/or walking in
forest, and breathing in the volatile substances released
by the trees [17]. Hence, we conducted a further litera-
ture review to evaluate the current evidence of spending
time in natural green environment, specifically, forest
bathing. Our research question is “what, if any, evidence
is there that forest bathing has effects on health, and if
so, what health indicators show improvement with this
exposure?”
Methods
Search strategy
A literature search was undertaken using the MEDLINE,
PubMed, ScienceDirect, EMBASE, and ProQuest Central
databases from inception up to December 2016. The key
words used were “Forest” or “Shinrin -Yoku” or “Forest
bath” AND “Health” or “Wellbeing”. A manual search of
the references of the retrieved articles was also under-
taken. Inclusion criteria were publications that reported
the effects of forest exposure on health and well-being,
tested in the context of a randomized controlled trial
(RCT), adult participants, and with the full article pub-
lished in the English language. Epidemiological studies,
case studies, and qualitative and non-human trials were
excluded.
Data extraction
A review template was developed specifying the key in-
formation to be extracted from each study and to assess
quality as shown in headings in Tables 1 and 2. Two re-
viewers (BO and KL) independently applied the inclu-
sion and quality assessment criteria. The two reviewers
compared results and resolved any disagreement
concerning items related to the published articles.
Quality assessment of RCT
The Cochrane risk of bias (ROB) tool (version 5.1.0)
[29] was used to evaluate the quality of the RCTs. The
ROB assessment tool has seven domains including
random sequence generation, allocation concealment,
blinding of participants and personnel, blinding of out-
come assessment, incomplete outcome data, selective
outcome reporting, and other sources of bias [29]. Two
reviewers (BO and KL) ascertained the ROB for each do-
main by indicating high risk, low risk, or unclear risk
and resolved disagreements by consensus.
Results
Study characteristics
The searches identified 32 potentially relevant articles
based on the search terms, of which, 26 articles were ex-
cluded as they did not meet the eligibility criteria. Five
articles were identified as RCTs including quantitatively
measured outcome assessments and were included. An
additional RCT was found in a reference list and was in-
cluded in the review (Fig. 1). Of these 6 RCTs, 3 studies
reported both psychological and physiological measures.
Across the 6 studies, the total number of participants
was 323. Sample sizes varied from 18 to 99. Three
studies had small samples (≤ 60). The other three
studies’ sample sizes were all greater than 60 (ranged
61–99). Age of participants ranged from 20 to 79 years.
Study population varied from young healthy university
students to elderly with chronic disease. Of the 323
participants, 72% (n = 233) had diagnosed medical condi-
tions [chronic alcoholic (n = 92), hypertension (n = 24),
exhaustion disorder (n = 99), and chronic obstructive
pulmonary disease (COPD) (n = 18)]. The studies were
performed in China (n = 3), Korea (n = 2), and Sweden
(n = 1). The duration of forest therapy interventions
varied across the studies, ranging from 1 day to
11 weeks. Most forest interventions were conducted
with short-term interventions ranging from 1 to
9 days: 1 day (n = 2), 2 days (n = 1), 7 days (n = 1),
and 9 days (n = 1), but one study was carried out over
11 weeks. Outcome measures varied across the stud-
ies using different instruments to measure the effect
of forest therapy on physical health and psychological
outcomes. Additionally for three studies, several bio-
markers were used to measure the effects on physio-
logical outcomes that were dependent on the
participants’ medical symptoms. No adverse events
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were reported. Only one study reported the samples
size calculation in relation to the statistical power.
Physiological response
Blood pressure
Two studies reported a positive impact on blood
pressure (BP). One study conducted in participants with
essential hypertension (n = 24) reported that participants
exposed to the forest environment showed a significant
reduction in BP compared to the urban intervention
group (p < 0.05) [19]. In addition to blood pressure, the
values of biomarkers (endothelin-1 (ET-1), homocysteine
(Hcy), angiotensinogen (AGT), angiotensin (AT)1) in
participants exposed to the forest environment were also
lower than those in the urban control group (p < 0.05).
The second study evaluated the effect of forest walking
on elderly women (n = 70) and reported that the forest
intervention group significantly reduced BP from pre to
Table 2 Assessment of risk of bias based on the Cochrane risk of bias tool
Fig. 1 Flowchart of the study selection process
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post forest exposure, while no significant changes were
observed in a city walking group [30]. This study did not
report the difference of BP between groups.
Immune function
One study reported a positive effect from forest therapy
on immune function. They found significant decreases
in the expression of perforin (natural killer cells(NK
cells), NK-like, CD8+ T cells) (p < 0.05) and granzyme B
expressions (NK cells, NK-like, cluster of differentiation
(CD)8+ T cells) which were associated with the patho-
genesis of chronic obstructive pulmonary disease
(COPD) after 1 day spent in a forest environment, while
there was no differences detected in the urban interven-
tion group [31].
Inflammation
Three RCTs reported favorable changes of pro-
inflammatory cytokines and C-reactive protein (CRP)
[19, 31, 32] in the forest intervention group. Two of
these studies evaluated the effect of forest intervention
on inflammation compared to an urban intervention. A
study conducted with essential hypertension patients
showed that the interleukin-6 (IL-6) level was signifi-
cantly reduced in the forest pre-post intervention group
(p < 0.05) but not in urban control group. Further, it re-
ported that the tumor necrosis factor α (TNF-α) level
did not change in either group [19]. However, a study
conducted with young university students by the same
investigator reported that both IL-6 and TNF-α levels
were significantly lower in the forest intervention group
compared to the urban intervention group (p < 0.05)
[32]. Another recent RCT conducted with COPD
patients reported that pro-inflammatory cytokines (IFN-
γ, IL-6, IL-8, IL-1β) and CRP were lower in the forest
group compared to the urban group (p < 0.05) [31].
Oxidative stress and antioxidant
One study evaluated the effect of forest therapy on oxi-
dative stress and antioxidant levels on young college stu-
dents [32]. Oxidative stress and antioxidant activity were
evaluated using the biomarkers of malondialdehyde
(MDA) and superoxide dismutase (SOD), respectively.
Results showed significant differences in MDA in the
forest intervention group compared to the urban group
(p < 0.001) but not for SOD.
Cardiac and pulmonary function
One study examined the effect of forest intervention on
arterial stiffness and pulmonary function in elderly
women [30]. Arterial stiffness and pulmonary function
were measured with cardio-ankle vascular index (CAVI)
that measures arterial stiffness of the artery from the
heart to the ankles and Vitalograph, Copd-6 m
respectively. Results of this study showed that there were
significant differences in changes of CAVI (p < 0.01),
forced expiratory volume in 1 s (forced expiratory vol-
ume (FEV1)) (p = 0.02), and forced expiratory volume in
6 s (FEV6) (p = 0.04) in the forest walking group com-
pared to the urban walking group.
Stress and stress hormone
One study evaluated stress levels in women diagnosed
with exhaustion disorder (ED). Their stress level was mea-
sured with the Perceived Stress Questionnaire (PSQ). This
study reported that both the forest intervention and con-
trol (waiting list) group decreased stress after a 3-month
intervention period but there was no difference between
the groups [33]. Another study evaluated the effect of for-
est intervention on the stress hormone serum cortisol and
reported that cortisol levels were significantly lower in the
forest intervention group compared to the urban interven-
tion group (p < 0.01) [32].
Psychological outcomes
Anxiety and depression
Two studies measured the effect of the forest environ-
ment intervention on anxiety and depression. One study
involved alcoholics which measured depression with the
Beck Depression Inventory (BDI) and reported signifi-
cant improvement of depression for the forest interven-
tion group compared to the usual care control group
(p < 0.001) [10]. In contrast, another study evaluated
the outcome of anxiety and depression with the
Hospital Anxiety and Depression Scale (HADS) in
women diagnosed with exhaustion disorder (ED) and
reported that both the forest intervention and the wait-
list control groups improved their anxiety and depres-
sion scores after 3-month intervention period with no
significant difference between the groups [33].
Mood
Three studies measured psychological responses with
profile and mood state questionnaire (POMS) which is
used to measure mood disorders [19, 31, 32]. Study pop-
ulations were diagnosed with hypertension [19] and
COPD [31] and included healthy university students
[32]. Studies reported that the forest therapy interven-
tion group had significantly lower scores in the negative
subscales (tension-anxiety, depression, anger-hostility,
fatigue, and confusion) [19, 31, 32] and increased vigor
(p < 0.05) [19, 32].
Assessment of risk of bias
In the assessment of random sequence generation, two
RCTs had low ROB and four had unclear ROB. Two
studies reported the method of random sequence gener-
ation while four studies did not describe the process.
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Five RCTs had high ROB for allocation concealment due
to lack of reporting the allocation concealment process.
Only one study described in detail the method of alloca-
tion concealment. All studies had a high ROB in the
blinding of participants and personnel. The blinding of
participants and study personnel is one of the main limi-
tations in the forest intervention study. Two RCTs had
high ROB and four RCTs had low ROB in blinding of
outcome assessment. Two studies measured outcome
with self-reported questionnaires. These can be influ-
enced by lack of blinding, whereas four RCTs measured
outcomes with biomarkers in addition to the self-
reported questionnaires to minimize the ROB.
Five RCTs had unclear ROB in incomplete outcome
data due to the lack of reporting missing outcome
data during their data analysis. One RCT had low
ROB, due to the reporting of details of missing out-
come data including the imputation of such missing
data, dropout rate, and statistical power. All RCTs had
low ROB in selective reporting. Six studies reported
on the aim of study, method of outcome assessment,
and results of all outcomes. In the assessment of other
sources of bias, three RCTs had small sample size
(< 50) and five RCTs had a short duration of forest
intervention (< 10 days).
Discussion
There continues to be conjecture about the value that
exposure to nature plays in human health and disease.
Numerous case studies and epidemiological and obser-
vational studies conducted with forest intervention re-
ported positive health and well-being outcomes among
the participants who spent time in a forest, and some
benefit was shown to be derived even with simply view-
ing natural environments. Previous literature reviews
attempted to synthesize the results of case studies and
epidemiological and observational studies to demon-
strate the positive effect of spending time in forest rather
than providing evidence based on RCTs. To our know-
ledge, to date, there has been no systemic literature re-
view conducted to assess the evidence of health and
well-being benefits of forest therapy based on RCTs.
Hence, this present review builds on the previous work
and goes further by including RCTs in the evaluation of
the evidence for the physiological and psychological
health and well-being benefits of forest therapy.
This present review found that six RCTs reported
promising therapeutic benefits of forest exposure on
several physical and psychological conditions including
hypertension, cardiac and pulmonary function, immune
function, inflammation, oxidative stress, stress, stress
hormone, anxiety, depression, and emotional response,
although outcomes of anxiety and depression had mixed
results and some inflammatory biomarkers showed null
results. These data show a consistent trend in a broad
range of health outcomes, suggesting potential for forest
bathing to improve physiological and psychological
health in healthy and health-compromised individuals,
but these results are drawn mostly from studies with
strong to moderate design weaknesses. All studies in-
cluded in this review had a high ROB (Fig. 1). Two of
the studies only reported the differences pre and post
intervention within each group, and even though they
found significant improvements within the forest therapy
group, they failed to report whether there was any differ-
ence between groups, thus not testing the significance of
between-group differences expected of an rigorously
evaluated RCT. Of the six RCTs, five evaluated only the
immediate or short-term effect of forest intervention
[1 day (n = 2), 2 days (n = 1), 7 days (n = 1), 9 days (n =
1)] without long-term follow-up. Only one RCT exam-
ined the effect of 11 weeks of forest intervention. Fur-
thermore, five studies were conducted with small sample
sizes and thus failed to meet statistical power required
to detect significant therapeutic effects, if any. None of
the studies were performed with blinding of subjects.
Moreover, none of the studies controlled for potential
bias or confounding factors (social interaction of subject,
physical activities, and forest environmental factors) dur-
ing the data analysis thus limiting conclusions which
may be drawn regarding the true therapeutic effect of
forests. Nonetheless, the present review findings are
consistent with previous reviews that suggest benefits;
however, the current findings need to be evaluated cau-
tiously due to the majority of the studies having risk of
bias, low sample sizes, and lack of control for participant
expectation effects [34, 35].
The present review did not find convincing evidence
of the benefits of forest therapy due to the lack of high-
quality studies. However, we cannot disregard the poten-
tial impact of nature in the form of forest therapy on
health and disease. The concept of human health and
longevity and its relationship with the natural environ-
ment has a long history [36]. Several studies suggest that
exposure to a green environment is associated with a
positive impact on physical and psychological well-being
including recovery from illness and even decrease mor-
tality [23, 37, 38]. A recent study also revealed that
therapeutic benefits from nature and more specifically a
green environment may be dose-dependent [8]. It ap-
pears likely that the therapeutic benefit of forest therapy
is multi-factorial. It may be induced by the complex eco-
system as a whole such as the green scenery, fresh air,
sunlight, clean water, rocks, soil, soothing sounds of
streams, waterfalls, birds, and natural aromas of trees,
plants, and flowers [39].
Taking into account the complexity of existing re-
search on the therapeutic benefits of nature, researchers
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should consider the following suggestions to improve
the rigor of future studies.
First, evaluation of both short-term intervention
(1 week) and long-term intervention (12 weeks) duration
is recommended, with multiple follow-ups in the post
intervention phase (3 months, 6 months, and 12 months).
The dose-response relationship should be examined by
varying length (e.g., 30 versus 60 versus 90 min), fre-
quency (e.g., weekly versus biweekly versus every 4 weeks),
and intensity of intervention, as measured by a physical
activity intensity scale.
Next, the lack of participant blinding in most of these
forest intervention studies could be remedied. When the
study design is a forest versus city outdoor exposure
comparison, having participants believe they are in-
volved in a “walking” study would blind the urban vs.
forest walkers to the expected outcome. There may be a
benefit in designing a study that also controls for the
outdoor activity, for example a three-arm design (forest
versus urban walking versus either a waitlist group or an
indoor reading group). Adequate sample size is recom-
mended to detect statistical and clinical significance;
future studies should include power calculations for
sample size selection. Moreover, it is recommended that
future studies utilize both quantitative and qualitative
approaches that will capture the complexity of the forest
environment effect. Measurement of disease-specific
biomarkers (e.g., cancer makers for the oncology patient)
and overall well-being biomarkers (e.g., immune func-
tion, cytokines, and DNA damage) may provide objective
information on the physiological and psychological
effects of forest intervention. Finally, a cost-benefit ana-
lysis of forest intervention should be conducted in order
to support the possible implementation of forest therapy
from a health economics perspective.
Conclusion
The objective in this review was to evaluate the health
and well-being benefits of a specific type of exposure to
nature, forest therapy based on RCTs. In conclusion,
strong evidence of the benefits of forest environment on
health and well-being has yet to be confirmed. The find-
ings of this review support the premise that exposure to
a forest environment may provide benefits. However, the
evidence is insufficient due to methodological design
flaws. Future research studies with more robust design is
warranted. While the beneficial effects of forest therapy
require further investigation, given that the intervention
has low risk of adverse effects and the likelihood that
such a recommendation would also increase outdoor ac-
tivity, policy makers and health professionals should
consider recommending forest therapy to their patients
and the general public.
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